CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN - UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP

被引：224

作者：

HOLFORD, NHG

机构：

来源：

关键词：

D O I：

10.2165/00003088-198611060-00005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：483 / 504

页数：22

共 99 条

[1] AARONS L, 1986, 3RD WORLD C CLIN PHA, P55
[2] EVALUATION OF A COMPUTER-ASSISTED METHOD FOR INDIVIDUALIZED ANTICOAGULATION - RETROSPECTIVE AND PROSPECTIVE STUDIES WITH A PHARMACODYNAMIC MODEL
ABBRECHT, PH
OLEARY, TJ
BEHRENDT, DM
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) : 129 - 136
[3] ABBRECHT PH, 1972, CLIN APPLICATION MAT
[4] PHENYLBUTAZONE-WARFARIN INTERACTION IN MAN - FURTHER STEREOCHEMICAL AND METABOLIC CONSIDERATIONS
BANFIELD, C
OREILLY, R
CHAN, E
ROWLAND, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) : 669 - 675
[5] BARR W, 1975, ASHP I ADV PHARMACOK
[6] THE NONMEM SYSTEM
BEAL, S
SHEINER, L
[J]. AMERICAN STATISTICIAN, 1980, 34 (02) : 118 - 119
[7] BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P316
[8] BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P322
[9] BRECKENRIDGE A, 1974, CLIN PHARMACOL THER, V15, P424
[10] BRECKENRIDGE A, 1973, CLIN PHARMACOL THER, V14, P955